Navigation Links
Dan Renick, RPh, Joins The Hobart Group as Managing Partner
Date:5/28/2008

Strengthens firm's ability to drive clients' success in managed care

GLADSTONE, N.J., May 28 /PRNewswire/ -- The Hobart Group, a full-service managed market agency focused on securing formulary access for today's pharmaceutical brands, announces the addition of Dan Renick, RPh, as Managing Partner. Renick will provide strategic counsel to The Hobart Group's pharmaceutical and biotech clients, including GlaxoSmithKline, sanofi-aventis, and Forest Laboratories.

"Dan brings a unique managed care perspective to The Hobart Group and our clients," said Lisa B. Bair, President. "His knowledge of what matters to payers during the formulary decision process, in particular, Medicare Part D, will help address a critical need for our clients."

"There is more pressure than ever on drugmakers to maximize revenues of their key assets. In today's market, it's critical that companies are able to effectively differentiate their drugs from the competition," said Renick. "I'm excited to apply my knowledge of what payers are looking for with our clients. As the healthcare environment evolves, it is critical to provide our managed market customers with strategies that deliver innovative solutions to obtaining formulary access."

Prior to joining The Hobart Group, Renick served as Director, Corporate Pharmacy Management, at Humana Inc., a national managed care organization with more than 11 million members and the second largest Medicare Part D and Medicare Advantage sponsor. In this role, Renick was responsible for Pharmacy Programs and trade relations, including contracting oversight with both pharmaceutical companies and pharmacy provider organizations. At Merck & Co., Inc., Renick worked with large employers, business coalitions, and benefits consultants in support of rational and evidence-based benefit-design decisions.

In addition, he has worked with various other managed market segments with an emphasis on Senior Care, and spent several years in pharmacy operations at the regional and headquarters level for both retail and long-term care pharmacy providers. Renick earned his RPh degree from the University of Kentucky and his BS degree in chemistry and biology from Western Kentucky University.

About The Hobart Group

The Hobart Group is a full-service managed market agency providing specialized services aimed at obtaining formulary access. The Hobart Group has developed a full suite of technology tools to help enhance relationships with payer customers. For more information about The Hobart Group, visit http://www.thehobartgroup.com.


'/>"/>
SOURCE The Hobart Group
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces ... at the Company,s Annual and Special Meeting. ... place on Thursday, December 15, 2016 at Mount ... EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta ... meeting and management information circular, containing the matters to be ...
Breaking Biology Technology:
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
Breaking Biology News(10 mins):